|
KLHL14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67486999999023E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17750000000017E-05 |
| Normal-vs-Stage2 |
4.704400E-03 |
| Normal-vs-Stage3 |
3.16519999998821E-06 |
| Normal-vs-Stage4 |
1.171850E-04 |
| Stage1-vs-Stage2 |
3.053600E-01 |
| Stage1-vs-Stage3 |
2.806400E-01 |
| Stage1-vs-Stage4 |
6.018800E-01 |
| Stage2-vs-Stage3 |
1.173590E-01 |
| Stage2-vs-Stage4 |
2.703400E-01 |
| Stage3-vs-Stage4 |
8.007400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89398000000063E-05 |
| Normal-vs-AfricanAmerican |
3.140000E-03 |
| Normal-vs-Asian |
2.10259999999796E-06 |
| Caucasian-vs-AfricanAmerican |
6.749000E-01 |
| Caucasian-vs-Asian |
2.127600E-01 |
| AfricanAmerican-vs-Asian |
2.202800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.216680E-04 |
| Normal-vs-Female |
3.28880000000087E-06 |
| Male-vs-Female |
1.941550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.82766999999862E-05 |
| Normal-vs-Age(41-60Yrs) |
1.88063999999599E-05 |
| Normal-vs-Age(61-80Yrs) |
1.610110E-04 |
| Normal-vs-Age(81-100Yrs) |
5.788400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.388600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.042600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.808400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.279600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.996600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.302600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.176280E-04 |
| Classical-VS-Follicular |
3.479600E-01 |
| Classical-VS-Other |
6.914400E-01 |
| Classical-VS-Normal |
6.01759999999674E-05 |
| Tall-VS-Follicular |
8.40980000000879E-05 |
| Tall-VS-Other |
1.442150E-01 |
| Tall-VS-Normal |
7.50969997298512E-09 |
| Follicular-VS-Other |
4.857200E-01 |
| Follicular-VS-Normal |
1.224040E-03 |
| Other-VS-Normal |
3.924500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.83810000000362E-05 |
| Normal-vs-N1 |
1.04009999501997E-08 |
| N0-vs-N1 |
2.247500E-04 |
|
|
